2024

1. Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain

   AIDS Patient Care and STDs, Vol. 38, Núm. 7, pp. 305-314

2. Assessing illness-related uncertainty in relapsing-remitting multiple sclerosis: A psychometric analysis of the Mishel Uncertainty of Illness Scale

   Multiple Sclerosis Journal - Experimental, Translational and Clinical, Vol. 10, Núm. 2

3. Assessment of bleeding events in patients receiving DOACs with or without statins to treat venous thromboembolism: insights from the RIETE registry

   BMJ open, Vol. 14, Núm. 10, pp. e085401

4. Association between type 2 diabetes and depressive symptoms after a 1-year follow-up in an older adult Mediterranean population

   Journal of Endocrinological Investigation, Vol. 47, Núm. 6, pp. 1405-1418

5. Association of microbiological factors with mortality in Escherichia coli bacteraemia presenting with sepsis/septic shock: a prospective cohort study

   Clinical Microbiology and Infection, Vol. 30, Núm. 8, pp. 1035-1041

6. At-admission prediction of mortality and pulmonary embolism in an international cohort of hospitalised patients with COVID-19 using statistical and machine learning methods

   Scientific Reports, Vol. 14, Núm. 1

7. Author Correction: Effectiveness and safety of XEN63 in patients with primary-open-angle glaucoma (Scientific Reports, (2024), 14, 1, (4561), 10.1038/s41598-024-55287-z)

   Scientific Reports

8. BRAF mutational status is associated with survival outcomes in locally advanced resectable and metastatic NSCLC

   Lung Cancer, Vol. 194

9. Bone and vascular effects of magnesium supplements in CKD patients (the MagicalBone Pilot Study)

   Nefrologia, Vol. 44, Núm. 5, pp. 721-730

10. Clinical Management and Outcomes of Nontuberculous Mycobacterial Infections in Solid Organ Transplant Recipients: A Multinational Case-control Study

    Transplantation

11. Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry

    Therapeutic Advances in Gastroenterology, Vol. 17

12. Clinical characteristics and impact on patient-reported outcomes and quality of life of people with ambulatory secondary progressive multiple sclerosis: Discover study

    Multiple Sclerosis and Related Disorders, Vol. 90

13. Clinical characteristics, predisposing factors and outcomes for Enterococcus faecalis versus Enterococcus faecium bloodstream infections: a prospective multicentre cohort study

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 10, pp. 2011-2022

14. Combination of granulocyte–monocyte apheresis and tofacitinib: Multicentre and retrospective study

    Gastroenterologia y Hepatologia, Vol. 47, Núm. 7, pp. 727-733

15. Combination of granulocyte–monocyte apheresis and ustekinumab: Multicentre and retrospective study

    Gastroenterologia y Hepatologia

16. Coronavirus disease 2019 is associated with long-term depressive symptoms in Spanish older adults with overweight/obesity and metabolic syndrome

    Psychological Medicine, Vol. 54, Núm. 3, pp. 620-630

17. Correction in article by Juzga-Corrales et al. “Characteristics and outcomes of the Spanish registry for pediatric patients with bicuspid aortic valve (REVAB)”, Rev Esp Cardiol. 2023;76:961-969 (Revista Española de Cardiología (English Edition) (2024) 77(4) (358–359), (S1885585724000331), (10.1016/j.rec.2023.12.011))

    Revista Espanola de Cardiologia

18. Corrigendum to “Recommendations for the use of anti-dsDNA autoantibodies in the diagnosis and follow-up of systemic lupus erythematosus – A proposal from an expert panel” [Autoimmunity Reviews, Volume 22, Issue 12, December 2023, 103479] (Autoimmunity Reviews (2023) 22(12), (S1568997223002136), (10.1016/j.autrev.2023.103479))

    Autoimmunity Reviews

19. Criteria and indicators to evaluate quality of care in genitourinary tumour boards

    Clinical and Translational Oncology, Vol. 26, Núm. 7, pp. 1639-1646

20. Decisional Conflict Regarding Disease-Modifying Treatment Choices Among Patients with Mid-Stage Relapsing-Remitting Multiple Sclerosis

    Patient Preference and Adherence , Vol. 18, pp. 1163-1171